PAREXEL's Kate Trainor, VP, Comments on Trends in Innovation at DIA

June 18, 2014
One of the key trends we're seeing here at DIA is innovation and it's innovation around many different things: around getting to sites and patients and being able to manage the communications with them independent of a particular study or therapeutic area. Innovation is important now for our clients because they're trying to get their products to market faster. It's always about that. Today, in particular, it's very important that they have the ability to use the resources that are available, specifically to get to sites and patients and to be able to manage those interactions better. Often times, that may include using an innovative technology, like the standard World Wide Web in an innovative way to be able to retain the attention of the patients and maintain them from recruitment through the life of a project. PAREXEL can simplify drug development for our customers by using our global expertise. We can also solve many complex problems and we'd like to leverage our long a strong relationships with many different clients.
Previous Video
PAREXEL's Chuck Stevens, VP, Comments on Key Trends at DIA
PAREXEL's Chuck Stevens, VP, Comments on Key Trends at DIA

The theme for this year's DIA is "Invest in the Future" and to that end, I've seen three tracks that speak ...

Next Video
PAREXEL's Cindie Kazmer Comments on New ClinPhone RTSM Functionality
PAREXEL's Cindie Kazmer Comments on New ClinPhone RTSM Functionality

PAREXEL Informatics just announced new capabilities on our ClinPhone RTSM, or randomization trial supply ma...